Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

How the Obamacare Verdict Could Crush Drugmakers
Motley Fool
Wednesday, June 27, 2012 - 10:19am
tags:
healthcare reform
Bristol-Myers Squibb boosts share buyback authorization by $3 billion
Yahoo/AP
Wednesday, June 27, 2012 - 10:16am
tags:
stock buyback, Bristol-Myers Squibb
It's Hard to Sell a Drug Like That
Motley Fool
Wednesday, June 27, 2012 - 10:15am
tags:
Eliquis, Pfizer, Bristol-Myers Squibb, FDA
Is Johnson & Johnson stuck in limbo?
Yahoo/optionMONSTER
Wednesday, June 27, 2012 - 10:14am
tags:
JNJ
Can Anything Stop Alexion Pharmaceuticals?
Motley Fool
Wednesday, June 27, 2012 - 10:13am
tags:
Alexion
Merck to keep recording income from Astra drugs
Reuters
Wednesday, June 27, 2012 - 10:13am
tags:
Merck, AstraZeneca, Nexium, Prilosec
Affymetrix Closes eBioscience Deal
Yahoo/Zacks
Tuesday, June 26, 2012 - 2:01pm
tags:
eBioscience, Affymetrix, M&A
3 Pharmaceutical Companies Seeing Insider Buys In Last 30 Days
Seeking Alpha
Tuesday, June 26, 2012 - 1:46pm
tags:
Enzon, Durect Corporation, OncoGenex
Survey: Future for Mobile Tech in Clinical Trials
Pharmalot
Tuesday, June 26, 2012 - 1:29pm
tags:
clinical trials, mobile
Supernus rockets 130% on FDA update
Marketwatch
Tuesday, June 26, 2012 - 1:28pm
tags:
Supernus Pharmaceuticals, FDA, Trokendi, epilepsy
Novartis, four others weigh Amylin final bids: sources
Reuters
Tuesday, June 26, 2012 - 1:26pm
tags:
Novartis, Amylin, M&A, Bristol-Myers Squibb, AstraZeneca, Merck, Sanofi
Onyx At High Seen Poised To Reap 40% More In Any Takeover
Bloomberg
Tuesday, June 26, 2012 - 12:02pm
tags:
M&A, ONYX Pharmaceuticals
Dynavax announces FDA acceptance of HEPLISAV BLA
Yahoo/Fly on the Wall
Tuesday, June 26, 2012 - 12:00pm
tags:
Dynavax, Heplisav, FDA, hepatitis B
Merck Overstated Mumps Vaccine Effectiveness?
Pharmalot
Tuesday, June 26, 2012 - 11:59am
tags:
mumps, Merck, MMR, vaccines
United Therapeutics Growing Drug Franchise
Seeking Alpha
Tuesday, June 26, 2012 - 11:58am
tags:
United Therapeutics, Alexion, Questcor, GSK, Pfizer, Eli Lilly
Watson says it is challenging patents on antidepressant Pristiq; Pfizer files lawsuit
Yahoo/AP
Tuesday, June 26, 2012 - 11:56am
tags:
Pristiq, Pfizer, Watson Pharmaceuticals, antidepressants, patents
Johnson & Johnson: A Lucrative Buy On Synthes Acqusition
Seeking Alpha
Tuesday, June 26, 2012 - 11:55am
tags:
J&J, M&A, Synthes
Prescription Painkiller Abuse Surged In U.S., Study Finds
Bloomberg
Tuesday, June 26, 2012 - 11:54am
tags:
painkillers, drug abuse
FDA: Amylin Pharma Concealed Heart Safety Risks of Key Diabetes Drug
TheStreet.com
Monday, June 25, 2012 - 3:29pm
tags:
FDA, Amylin, Byetta, diabetes
Pharma Execs Say The Future Looks Like This…
Pharmalot
Monday, June 25, 2012 - 3:27pm
tags:
pharma execs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.